Huons Dapagliflozin 10 mg (Dapagliflozin Anhydrous Mixture)
Dapagliflozin Anhydrous Lactose Mixture 15.27mg
Tablet · Prescription medication
Huons Co., Ltd.
MFDS item code 202005365 · Approved 2020.07.23
This product's status changed to Expired on 2025.07.23. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to help control blood sugar in patients with type 2 diabetes. It can be administered as an adjunct when patients find it difficult to manage blood sugar with diet and exercise and can also be used alone. If blood sugar is not adequately controlled, it can be used in combination with other medications such as metformin, sulfonylureas, insulin, and sitagliptin for more effective blood sugar management. It helps improve blood sugar control in patients when used with various combination therapies. This medication is used to enhance blood sugar control in type 2 diabetes.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received diabetes medication, the recommended initial dose of this medicine when administered in combination with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, 5 mg is recommended as the starting dose. If well tolerated, this dose may be increased to 10mg. Elderly (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This medication should not be used in patients with a history of allergic reactions to the active ingredient or excipients. It should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. This medication contains anhydrous lactose, which should not be used in patients with problems in lactose metabolism or genetic issues such as galactose intolerance. Patients undergoing renal dialysis should not use this medication. Patients with reduced fluid volume or renal impairment should use this medication cautiously, and blood pressure and renal function should be monitored carefully before and during administration. Particularly, elderly patients or those on diuretics are at higher risk of hypotension or decreased fluid volume, so caution is needed. This medication contains colorants Yellow No. 4 and Yellow No. 5, and should be used with caution in patients with a history of allergic reactions. In clinical trials, the most common side effect was genital infections, occurring more frequently in women, particularly in those with a history of infections, where the likelihood of recurrence is increased. Hypoglycemia may occur when using this medication, particularly when used with insulin or sulfonylureas, and dosage adjustments may be needed. Symptoms of dehydration or hypotension due to reduced fluid volume can occur, and immediate consultation with healthcare personnel is advised if such symptoms arise. Diabetic ketoacidosis may rarely occur, so patients should seek immediate medical attention if symptoms such as vomiting, abdominal pain, or difficulty breathing appear. There may be an increased risk of urinary tract infections and pyelonephritis, and rapid treatment is necessary if there are any abnormal urination symptoms. In patients with impaired renal function, there may be a temporary increase in serum creatinine levels, thus regular monitoring of renal function is required. Severe infections such as necrotizing fasciitis have been rarely reported, so any pain, swelling, or redness in the genital area should be promptly reported to healthcare personnel. This medication is not recommended during pregnancy, and usage should be discontinued if pregnancy is confirmed. Lactating women are advised not to use this medication. Safety and efficacy in children and adolescents have not been established. There is no specific antidote for overdose, and treatment should be symptomatic as directed by a physician. This medication does not significantly affect driving or machine operation, but awareness of the risk of hypoglycemia should be recognized if used with insulin or sulfonylureas.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. Additionally, it is recommended to store the medication at room temperature between 1 degree and 30 degrees Celsius to maintain its efficacy and prevent degradation.
Yellow, biconvex, diamond-shaped film-coated tablet
28 tablets/box [7 tablets/PTPX 4]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Dapagliflozin Anhydrous Lactose Mixture 15.27mg
Tablet · Prescription medication
Huons Co., Ltd.
Dapagliflozin Anhydrous Lactose Mixture 7.635mg
Tablet · Prescription medication
International Pharmaceuticals Co., Ltd.

Dapagliflozin Anhydrous Lactose Mixture 15.27mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.
Dapagliflozin Anhydrous Lactose Mixture 7.635mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Dapagliflozin Anhydrous Lactose Mixture 15.27mg
Tablet · Prescription medication
Sinil Pharmaceutical Co., Ltd.
Dapagliflozin Anhydrous Lactose Mixture 7.635mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Dapagliflozin Anhydrous Lactose Mixture 15.27mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.
Dapagliflozin Anhydrous Lactose Mixture 7.635mg
Tablet · Prescription medication
Albozen Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.